xtandi
astellas pharma europe b.v. - enzalutamide - prostatas audzēji - endokrīnā terapija - xtandi is indicated for:the treatment of adult men with metastatic hormone-sensitive prostate cancer (mhspc) in combination with androgen deprivation therapy (see section 5. the treatment of adult men with high-risk non-metastatic castration-resistant prostate cancer (crpc) (see section 5. the treatment of adult men with metastatic crpc who are asymptomatic or mildly symptomatic after failure of androgen deprivation therapy in whom chemotherapy is not yet clinically indicated (see section 5. the treatment of adult men with metastatic crpc whose disease has progressed on or after docetaxel therapy.
indovasin 30/20 mg/g gels
actavis nordic a/s, denmark - indometacinum, troxerutinum - gels - 30/20 mg/g
rosuchen 20 mg apvalkotās tabletes
antibiotice s.a., romania - rosuvastatīns - apvalkotā tablete - 20 mg
rosuchen 40 mg apvalkotās tabletes
antibiotice s.a., romania - rosuvastatīns - apvalkotā tablete - 40 mg
rosuchen 10 mg apvalkotās tabletes
antibiotice s.a., romania - rosuvastatīns - apvalkotā tablete - 10 mg
rosuchen 5 mg apvalkotās tabletes
antibiotice s.a., romania - rosuvastatīns - apvalkotā tablete - 5 mg
amlodipine/atorvastatin krka 10 mg/10 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - amlodipinum, atorvastatinum - apvalkotās tabletes - 10 mg/10 mg
atoris 60 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - atorvastatīns - apvalkotā tablete - 60 mg
atoris 80 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - atorvastatīns - apvalkotā tablete - 80 mg
atoris 30 mg apvalkotās tabletes
krka, d.d., novo mesto, slovenia - atorvastatīns - apvalkotā tablete - 30 mg